Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
38.22
-0.01 (-0.03%)
At close: Mar 9, 2026, 4:00 PM EDT
38.20
-0.02 (-0.05%)
After-hours: Mar 9, 2026, 6:16 PM EDT

Crinetics Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
4,0024,4174,7422,3779851,340
Upgrade
Market Cap Growth
17.07%-6.84%99.50%141.36%-26.50%188.40%
Upgrade
Enterprise Value
3,0223,3743,9321,8746201,151
Upgrade
Last Close Price
38.2246.5551.1335.5818.3028.41
Upgrade
PS Ratio
519.99573.964563.69592.26207.881242.80
Upgrade
PB Ratio
3.684.453.584.413.114.04
Upgrade
P/TBV Ratio
4.034.453.584.413.114.04
Upgrade
EV/Sales Ratio
392.74438.423783.97467.04130.821067.39
Upgrade
Debt / Equity Ratio
0.050.050.040.100.010.01
Upgrade
Net Debt / Equity Ratio
-0.99-0.99-0.98-0.94-1.05-0.99
Upgrade
Net Debt / EBITDA Ratio
1.911.913.882.291.993.09
Upgrade
Net Debt / FCF Ratio
2.552.555.572.932.843.70
Upgrade
Asset Turnover
0.010.010.000.010.010.00
Upgrade
Quick Ratio
12.0912.0922.6912.9212.1720.96
Upgrade
Current Ratio
12.3212.3223.0513.0712.4521.55
Upgrade
Return on Equity (ROE)
-40.17%-40.17%-32.02%-50.16%-50.57%-42.98%
Upgrade
Return on Assets (ROA)
-25.22%-25.22%-20.46%-28.18%-29.84%-25.19%
Upgrade
Return on Capital Employed (ROCE)
-49.60%-49.60%-24.60%-37.60%-51.70%-32.10%
Upgrade
Earnings Yield
-11.63%-10.53%-6.29%-9.03%-16.65%-8.04%
Upgrade
FCF Yield
-9.59%-8.69%-4.94%-7.29%-11.87%-6.64%
Upgrade
Buyback Yield / Dilution
-16.43%-16.43%-39.11%-11.71%-35.24%-26.24%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.